Companies that stop public subscription plans in the United States as markets for tariff tariffs

Digest opened free editor

Rola Khaleda, FT editor, chooses her favorite stories in this weekly newsletter.

A number of upcoming US initial offers, including $ 15 billion, were postponed by Fintech Klarana and Medtech Medtech worth $ 50 billion, as Roil Global Markets.

“Buy now, pay later” clearPeople familiar with this issue said that the surgical products backed by special stocks supported by Medline and Ticket Ticket Company Stubhub are aimed at advertising, but these plans have been suspended due to market turmoil. All companies have secretly raised plans to include stocks in recent months.

Once a company provides publicly Public subscription Paper works with the Securities and Stock Exchange Committee, they put themselves equally to launch the invested road batch after 15 days. Clarna was planning to launch her list of $ 15 billion next week, while MEDLINE, supported by Blackstone, Carlyle and Hello & Friedman, planned to publicly present it earlier this week, aiming to evaluate approximately 50 billion dollars, but both lists were delayed indefinitely.

People said that the Stumbhub and the Virtual Physiotherapy Company had publicly submitted their paper work last month and planned to start the retreats of investors in early April, but they are now suspended before the start of talks with potential investors. People added that companies were not committed to float within a specific time frame and the list could occur in the coming weeks.

Bloomberg late on Friday reported that the Israeli -based trading platform has also stopped plans for American public publication that submitted papers to follow last month.

The American public subscription market began to show some signs of life in recent weeks after a three -year dry talisman resulting from the high interest rates, with the data center operator Coruv Earlier this month, he made the largest technical shows since Holdings Ar in 2023.

But the fluctuation of the market unleashed Trump’s tariff The stock markets knocked and forced many companies that were hoping to get rid of. This represents a flagrant transformation since the beginning of the year, when many bankers said they expect the public subscription market to flourish under a pro -business management.

Global markets have Decline Since Trump has announced an experimental tariff for American trading partners this week. The losses were extended on Friday, as China announced reprisal measures and investors mitigating the possibility of a full global trade war.

S&P ended on Friday 6 percent, while the heavy NASDAQ boat in technology lost 5.8 percent.

Clarna declined to comment. Medline, Hinge Health and Stumbhub did not immediately respond to the comments.